Crohn Disease
📧 Sign up to get email alerts when something new happens for Crohn Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-12-18Clinical Trial Update: Prevalence of Helicobacter Pylori on Patients With Chronic Inflammatory Bowel Disease (IBD) at the CHU of Guadeloupe
A clinical trial is examining the prevalence of Helicobacter pylori infection in patients with inflammatory bowel disease at CHU de la Guade…
-
CLINICAL_TRIALS trial_result · 2025-12-17Clinical Trial Update: FMT for Postop Crohn's Disease [Phase 1]
Phase 1 trial assessing fecal microbiota transplant for postoperative Crohn's disease has completed.
-
CLINICAL_TRIALS research · 2025-12-16Clinical Trial Update: A Study for Imaging the Lower Gastrointestinal Tract Using a Retro-TCE Capsule [NA]
A clinical trial is evaluating imaging the lower gastrointestinal tract using a Retro-TCE Capsule and is currently recruiting at Massachuset…
-
CLINICAL_TRIALS trial_result · 2025-12-16Clinical Trial Update: COmparison of MicroBiota AccordIng to Age in Crohn's Disease (COMeBACk)
This is a completed clinical trial investigating how gut microbiota differs by age in Crohn's disease. The study, named COMeBACk, examines a…
-
EMA approval · 2025-12-15EMA Authorised: Remicade (infliximab) — Janssen Cilag International NV
The EMA has authorised Remicade (infliximab) for multiple inflammatory diseases under Janssen Cilag International NV as the marketing author…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-12-15Clinical Trial Update: A Long-term Extension Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease [Phase 3]
This entry covers a Phase 3 long-term extension study of mirikizumab in Crohn's disease, with results posted in December 2025.
-
CLINICAL_TRIALS trial_result · 2025-12-15Clinical Trial Update: Autologous Stem Cell Transplantation for Crohn's Disease [Phase 1, Phase 2]
A clinical trial is enrolling to evaluate autologous stem cell transplantation as a treatment for Crohn's disease in Phase 1/Phase 2.
-
CLINICAL_TRIALS research · 2025-12-15Clinical Trial Update: A Study to Investigate the Long-term Safety, Tolerability and Efficacy of Balinatunfib in Participants With Crohn's Disease or Ulcerative Colitis (SPECIFI-IBD-LTS) [Phase 2]
A Phase 2 clinical trial to evaluate the long-term safety, tolerability, and efficacy of Balinatunfib in participants with Crohn's disease o…
-
CLINICAL_TRIALS research · 2025-12-12Clinical Trial Update: A Randomized Crossover Trial of Bright Light Therapy in Crohn's Disease on Intestinal Barrier Homeostasis [NA]
A randomized crossover trial is evaluating bright light therapy for intestinal barrier homeostasis in Crohn's disease. The study is currentl…
-
EMA approval · 2025-12-11EMA Authorised: Hyrimoz (adalimumab) — Sandoz GmbH
EMA authorised Hyrimoz (adalimumab) by Sandoz GmbH as a biosimilar to Humira for multiple inflammatory diseases, including rheumatoid arthri…
-
CLINICAL_TRIALS trial_result · 2025-12-10Clinical Trial Update: VedAryo® (Vedolizumab) Effectiveness and Safety Evaluation
A completed study evaluating VedAryo (vedolizumab) for effectiveness and safety in ulcerative colitis and Crohn's disease. The update report…
-
CLINICAL_TRIALS trial_result · 2025-12-10Clinical Trial Update: The Nordic IBD Treatment Strategy Trial [Phase 4]
The Nordic IBD Treatment Strategy Trial has completed Phase 4.
-
CLINICAL_TRIALS research · 2025-12-10Clinical Trial Update: Robotic Inflammatory Bowel Disease Development, Learning and Efficacy Study
This is a clinical trial update about a robotic system for inflammatory bowel disease development, learning, and efficacy, which is currentl…
-
CLINICAL_TRIALS research · 2025-12-10Clinical Trial Update: Treatment of Moderate to Severe Refractory Crohn's Disease [Phase 1, Phase 2]
Ongoing Phase 1/Phase 2 clinical trials are evaluating a treatment for moderate to severe refractory Crohn's disease. Recruitment is current…
-
CLINICAL_TRIALS research · 2025-12-09Clinical Trial Update: Partial-enteral Nutrition Protocol for Crohn's Disease [NA]
A completed clinical trial investigating partial-enteral nutrition for Crohn's disease sponsored by Kate Farms.
-
CLINICAL_TRIALS trial_result · 2025-12-05Clinical Trial Update: A Study to Test the Effect of TEV-48574 in Moderate to Severe Ulcerative Colitis or Crohn's Disease [Phase 2]
A Phase 2 trial evaluating TEV-48574 for moderate-to-severe ulcerative colitis or Crohn's disease has completed with results posted.
-
CLINICAL_TRIALS research · 2025-12-05Clinical Trial Update: Safety and Efficacy of Capsule FMT in Treatment-naïve Patients With Newly Diagnosed Chronic Inflammatory Diseases [Phase 2]
Phase 2 trial evaluating the safety and efficacy of an oral capsule fecal microbiota transplant (FMT) in treatment-naïve patients with newly…
-
CLINICAL_TRIALS research · 2025-12-04Clinical Trial Update: The Association Between TNFSF4 Polymorphism and CD
A completed clinical trial evaluating the association between TNFSF4 polymorphisms and inflammatory bowel diseases, specifically Crohn's dis…
-
CLINICAL_TRIALS trial_result · 2025-12-04Clinical Trial Update: Postoperative REcurrence and DynamICs of T Cell Subsets in Crohn's Disease [Phase 3]
Phase 3 trial update examining postoperative recurrence and dynamics of T cell subsets in Crohn's disease. The trial status is completed.
-
CLINICAL_TRIALS trial_result · 2025-12-04Clinical Trial Update: A Study on the Relationship of Interleukin-7 Receptor Gene Polymorphisms With the Risk of Crohn's Disease Onset and the Efficacy of Infliximab
The study examined whether interleukin-7 receptor gene polymorphisms influence Crohn's disease risk and the efficacy of infliximab; the tria…
-
CLINICAL_TRIALS research · 2025-12-04Clinical Trial Update: Clostridium Butyricum in Stenosing Crohn's Desease [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating Clostridium butyricum in patients with stenosing Crohn's disease is not yet recruiting.
-
CLINICAL_TRIALS trial_result · 2025-12-03Clinical Trial Update: AZD7798 Safety, Tolerability, and Pharmacokinetics After a Single Ascending and Repeat Dose Administrations to Healthy Subjects, and Patients With Crohn's Disease [Phase 1]
Phase 1 study assessing safety, tolerability, and pharmacokinetics of AZD7798 after single ascending and repeat dosing in healthy subjects a…
-
CLINICAL_TRIALS research · 2025-12-03Clinical Trial Update: Real-World Study on Fecal Microbiota Transplantation: Long-Term Effectiveness and Safety Statistics
This clinical trial real-world study is assessing the long-term effectiveness and safety of fecal microbiota transplantation across several …
-
CLINICAL_TRIALS research · 2025-12-03Clinical Trial Update: Evaluation of Therapeutic Strategy to Prevent Crohn's Disease Endoscopic poSToperatIve recurreNce Based on earlY Dosage of Faecal Calprotectin [NA]
A clinical trial is evaluating whether an early fecal calprotectin-guided strategy can prevent endoscopic postoperative recurrence of Crohn'…
-
CLINICAL_TRIALS research · 2025-12-02Clinical Trial Update: A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD) [Phase 3]
This clinical trial entry describes a long-term extension study of vedolizumab in children and teenagers with ulcerative colitis or Crohn's …